Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer

Journal of Translational Medicine

Volumn 9, Issue , 2011, Pages

  Ablin, Richard J ^a   Kynaston, Howard G ^b   Mason, Malcolm D ^b   Jiang, Wen G ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 24; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 4; PROTEIN KINASE B; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CELL SURFACE RECEPTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24; TRANSGLUTAMINASE 4;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; BIOASSAY; CELL MOTION; CELL PROLIFERATION; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; PATHOLOGY; PROSTATE TUMOR; PROTEIN TRANSPORT; STAINING; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOLOGICAL ASSAY; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; INTERLEUKINS; MALE; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; STAINING AND LABELING; TRANSGLUTAMINASES;

EID: 79955154225     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-49     Document Type: Article

References (26)

1. Folk JE. Transglutaminases. Annu Rev Biochem 1980, 49:517-531. 10.1146/annurev.bi.49.070180.002505, 6105840.
2. Chen JSK, Mehta K. Tissue transglutaminase: an enzyme with a split personality. Int J Biochem Cell Biol 1999, 31:817-836. 10.1016/S1357-2725(99)00045-X, 10481269.
3. Gentile V, Grant FJ, Porta R, Baldini A. Localization of the human prostate transglutaminase (type IV) gene (transglutaminase-4) to chromosome 3p21.33-p22 by fluorescence in situ hybridization. Genomics 1995, 27:219-220. 10.1006/geno.1995.1032, 7665178.
4. Grant FJ, Taylor DA, Sheppard PO, Mathewes SL, Lint W, Vanaja E, Bishop PD, O'Hara PJ. Molecular cloning and characterization of a novel transglutaminase cDNA from a human prostate cDNA library. Biochem Biophys Res Commun 1994, 203:1117-1123. 10.1006/bbrc.1994.2298, 7916568.
5. Dubbink HJ, de Waal L, van Haperen R, Verkaik NS, Trapman J, Romijn JC. The human prostate-specific transglutaminase gene (TGM4): genomic organization, tissue-specific expression, and promoter characterization. Genomics 1998, 51:434-44. 10.1006/geno.1998.5393, 9721214.
6. Dubbink HJ, Hoedemaeker RF, van der Kwast TH, Schroder FH, Romijn JC. Human prostate-specific transglutaminase: a new prostatic marker with a unique distribution pattern. Lab Invest 1999, 79:141-150.
7. An G, Meka CS, Bright SP, Veltri RW. Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer. Urology 1999, 54:1105-1111. 10.1016/S0090-4295(99)00298-8, 10604718.
8. Cho SY, Jeon JH, Kim CW, Shin DM, Jang GY, Jeong EM, Lee SE, Song KY, Kim IG. Monoclonal antibodies to human transglutaminase 4. Hybridoma (Larchmt) 2010, 29:263-267.
9. Ho KC, Quarmby VE, French FS, Wilson EM. Molecular cloning of rat prostate transglutaminase (type IV) gene (transglutaminase-4) to chromosome 3p21.33p22 by fluorescence in situ hybridization. Genomics 1995, 27:219-220. 10.1006/geno.1995.1032, 7665178.
10. Williams-Ashman HG. Transglutaminases and the clotting of mammalian seminal fluids. Mol Cell Biochem 1984, 58:51-61. 10.1007/BF00240604, 6143253.
11. Ablin RJ, Whyard TC. Identification and biological relevance of spermatozoal transglutaminase. Experientia 1991, 47:277-279. 10.1007/BF01958159, 1672655.
12. Davies G, Ablin RJ, Mason MD, Jiang WG. Expression of the prostate transglutainase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer. J Exp Therapeut Oncol 2007, 6:257-264.
13. Jiang WG, Ablin RJ, Kynaston HG, Mason MD. The Prostate Transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway. Microvas Res 2009, 77:150-157.
14. Cho SY, Choi K, Jeon JH, Kim CW, Shin DM, Lee JB, Lee SE, Kim CS, Park JS, Jeong EM, Jang GY, Song KY, Kim IG. Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer. Exp Mol Med 2010, 42:310-318. 10.3858/emm.2010.42.4.031, 2859330, 20177144.
15. Jiang WG, Ablin RJ, Ye L, Kynaston, Mason MD. The prostate transglutaminase, TGase-4, coordinate with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells. Int J Oncology 2010, 37:413-418.
16. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995, 11:2477-2486.
17. Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CSH, Fisher PB. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc Nat Acad Sci USA 1996, 93:9160-9165. 10.1073/pnas.93.17.9160, 38612, 8799171.
18. Lebedeva IV, Sarkar D, Su ZZ, Su Z-Z, Kitada S, Dent P, Stein CA, Reed JC, Fisher PB. Bcl-2 and Bcl-XL differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. Oncogene 2003, 22:8758-8773. 10.1038/sj.onc.1206891, 14647471.
19. Jiang WG, Davies G, Martin TA, Parcc C, Watkins G, Mason MD, Mokbel K, Mansel RE. Molecular targeting of matrilysin and its impact on tumour growth in vivo, the potential implications in breast cancer therapy. Clin Cancer Res 2005, 11:6012-6019. 10.1158/1078-0432.CCR-05-0275, 16115946.
20. Jiang WG, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE, Fodstad O. Expression of Com-1/p8 in human breast cancer, and its relevance to clinical outcome and ER status. Int J Cancer 2005, 117:730-737. 10.1002/ijc.21221, 15957166.
21. Giaever I, Keese CR. Micromotion of mammalian cells measured electrically. Proc Natl Acad Sci USA 1991, 88:7896-7900. 10.1073/pnas.88.17.7896, 52411, 1881923.
22. Jiang WG, Martin TA, Russell-Lewis J, Ye L, Douglas-Jones A, Mansel RE. Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Mol Cancer 2008, 7:71. 2553413, 18796137.
23. Keese CR, Wegener J, Walker SR, Giaever I. Electrical wound-healing assay for cells in vitro. Proc Natl Acad Sci USA 2004, 101:1554-1559. 10.1073/pnas.0307588100, 341773, 14747654.
24. Gopalan B, Litvak A, Sharma S, Mhashilkar AM, Chada S, Ramesh R. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Cancer Res 2005, 65:3017-3024.
25. Zhao L, Dong A, Gu J, Liu Z, Zhang Y, Zhang W, Wang Y, He L, Qian C, Qian Q, Liu X. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer. Cancer Gene Ther 2006, 13:1011-1022. 10.1038/sj.cgt.7700969, 16799468.
26. Yacoub A, Mitchell C, Lebedeva IV, Sarkar D, Su ZZ, McKinstry R, Gopalkrishnan RV, Grant S, Fisher PB, Dent P. MDA-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling. Cancer Biol Ther 2003, 2:347-353.